Related Experiment Video
Updated: Aug 7, 2026

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
9-cis retinoic acid induces insulin-like growth factor binding protein-3 through DR-8 retinoic acid responsive
Yoon Soo Chang1, Jae Yong Cho, Hyun A Cho
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Abstract:
Retinoic acids, which have shown potential chemopreventive and therapeutic activities for several neoplastic diseases in vitro, modulate the growth-promoting and anti-apoptotic activities of insulin-like growth factors (IGFs), in part by influencing the expression of insulin-like growth factor binding protein-3 (IGFBP-3). This study sought to investigate the effect of 9-cis retinoic acid (9cRA) on the expression of IGFBP-3 and the underlying mechanisms involving retinoic acid receptor-beta (RAR-beta). The pharmacologic activity of 9cRA was characterized by monitoring target modulation as well as by evaluating the underlying mechanisms in NSCLC cells. Treatment of 9cRA inhibited proliferation of a part of NSCLC cell lines including H460 cells in clinically-achievable concentrations and induced IGFBP-3 expression in dose- and time-dependent manners. Transient transfection with a reporter constructs driven by the human IGFBP-3 gene promoter indicated that 9cRA induces gene expression via the -534 to -445 region (relative to translation start site) of the IGFBP-3 promoter. Unilateral deletion and site-directed mutagenesis identified a retinoic acid responsive element (RARE), a direct repeat of two GGGTCA-related hexanucleotides separated by just 8 bp (DR-8-type response element). A cotransfection assay with a RAR-beta expression vector potentiated (and with siRNA for RAR-beta, diminished) the effect of 9cRA on IGFBP-3 expression. IGFBP-3 gene expression by 9cRA is mediated by a distinct DR-8 RARE located in the proximal region of the IGFBP promoter and involves the RAR-beta, a putative tumor suppressor in NSCLC.
Insights
9-cis retinoic acid (9cRA) inhibits non-small cell lung cancer (NSCLC) proliferation and upregulates insulin-like growth factor binding protein-3 (IGFBP-3) expression. This effect is mediated by retinoic acid receptor-beta (RAR-beta) binding to a specific element in the IGFBP-3 promoter.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Retinoic acids exhibit chemopreventive and therapeutic potential in neoplastic diseases.
- Retinoic acids modulate insulin-like growth factors (IGFs) and insulin-like growth factor binding protein-3 (IGFBP-3) expression.
- Retinoic acid receptor-beta (RAR-beta) is implicated in cancer pathways.
Purpose of the Study:
- To investigate the effect of 9-cis retinoic acid (9cRA) on IGFBP-3 expression in non-small cell lung cancer (NSCLC) cells.
- To elucidate the underlying molecular mechanisms involving retinoic acid receptor-beta (RAR-beta).
Main Methods:
- Treatment of NSCLC cell lines with 9cRA.
- Reporter gene assays using the human IGFBP-3 promoter.
- Site-directed mutagenesis and deletion analysis to identify response elements.
- Co-transfection assays with RAR-beta expression vectors and siRNA.
Main Results:
- 9cRA inhibited proliferation of certain NSCLC cell lines, including H460 cells.
- 9cRA induced IGFBP-3 expression in a dose- and time-dependent manner.
- A retinoic acid responsive element (RARE) of DR-8 type was identified in the IGFBP-3 promoter (-534 to -445 region).
- RAR-beta potentiated 9cRA-induced IGFBP-3 expression, while its depletion diminished the effect.
Conclusions:
- 9cRA effectively inhibits NSCLC proliferation and upregulates IGFBP-3 expression.
- IGFBP-3 gene expression is mediated by a DR-8 RARE in the proximal promoter region.
- RAR-beta plays a crucial role in mediating the effects of 9cRA on IGFBP-3 expression, suggesting its potential as a tumor suppressor in NSCLC.
More Related Videos
09:04Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
09:49Quantitative Measurement of Relative Retinoic Acid Levels in E8.5 Embryos and Neurosphere Cultures Using the F9 RARE-Lacz Cell-based Reporter Assay
Published on: September 6, 2016
Related Concept Videos
TGF - β Signaling Pathway
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules